Background The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations
under therapeutic monoclonal antibody (mAb) pressure remains to be explored. Methods …

Background Lack of specific definitions of clinical characteristics, disease severity, and risk
and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and …

The ability to adapt to environmental stress, including therapeutic insult, contributes to tumor
evolution and drug resistance. In suboptimal conditions, the integrated stress response (ISR…

Simple Summary SARS-CoV-2 infection has been associated with broad dysregulation of
the circulating immune system and inflammation that could persist for a long period. Chronic …

Objectives The study aim was to assess predictors of negative antibody response (AbR) in
solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination. …

This study aimed to compare the clinical progression of COVID-19 in high-risk outpatients
treated with the monoclonal antibodies (mAb) bamlanivimab, bamlanivimab-etesevimab and …

The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019
(COVID-19) breakthrough infections is unclear. We present the results of an observational …

The recent decline in vaccination rates across Europe has led to outbreaks of vaccine
preventable diseases such as measles. Although there have always been persons opposed to …

Background Patients with cancer, especially hematological cancer, are at increased risk for
breakthrough COVID-19 infection. So far, a predictive biomarker that can assess …

Background Patients with cancer, especially haematological cancer, are at increased risk for
breakthrough COVID-19 infection. However, so far, a predictive biomarker that can assess …